Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Thomas M. who wrote (1362)	11/3/1998 11:26:00 AM
From: BMcV	Respond to of 10280

Amazing to see Barberich buying HMSR -- I'd pretty much given them up for dead after they lost their patent infringement case to Pall Corp. The real carrion in the Sepracor portfolio is BSEP, which has the original SEPR business, before they hit on the idea of patenting isomers of existing blockbuster drugs. Someday Sepracor will be a business class case study. TB and co have been extraordinarily foresighted and opportunistic in their attempt to build a major company. There is tremendous ambition and business intelligence behind their efforts and that is perhaps my chief reason for sticking with SEPR through all the ups and downs.